N-acetylglucosaminyltransferase V gene
US5602003A · kind A · utility
26Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 1993 |
| Grant date | Feb 11, 1997 |
| Priority date | — |
| Expiry date | Feb 10, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/1051
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides a substantially purified UDP-N-acetylglucosamine:.alpha.-6-D-mannoside .beta.-1,6-N-acetylglucosaminyltransferase (GlcNAc T-V; EC 2.4.1.155) and antibodies which specifically bind GlcNAc T-V. The present invention also provides polynucleotide sequences and oligonucleotide probes capable of specifically hybridizing to nucleic acid sequences which encode GlcNAc T-V, and cDNA and genomic clones encoding GlcNAc T-V, as well as nucleotide sequences encoding GlcNAc T-V, as specifically exemplified by a GlcNAc T-V coding sequence from rat.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.